Neurochemical changes following the administration of precursors of biogenic amines.
D006916:5-Hydroxytryptophan / Q000378:metabolism*; D000109:Acetylcholine / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D002794:Choline / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D007980:Levodopa / Q000378:metabolism*; D008297:Male; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism*; D014443:Tyrosine / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000596:Amino Acids; D018377:Neurotransmitter Agents; D012701:Serotonin; D014443:Tyrosine; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D002794:Choline; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine